Alan P. Lyss, MD

Differences in tumor characteristics could explain sex- and race-based disparities in patients with metastatic non-small cell lung cancer.

A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.

Sublobar resection is noninferior to a full lobectomy in patients with carefully staged cT1aN0 non-small cell lung cancer, new research suggests.

Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.

The 2-year overall survival rate was 32.5%.

A meta-analysis revealed inferior responses, progression-free survival, and overall survival in patients exposed to antibiotics.

Data suggest nivolumab plus ipilimumab provides a long-term survival benefit in patients with unresectable malignant pleural mesothelioma.

The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.